Skip to main content

Zafirlukast

NDC 55111-625 · Dr. Reddys Laboratories Limited

Generic nameZafirlukast
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ZAFIRLUKAST
Strength10 mg/1
Pharmacologic classCytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

55111-625-01 — 100 TABLET, FILM COATED in 1 BOTTLE (55111-625-01)

55111-625-05 — 500 TABLET, FILM COATED in 1 BOTTLE (55111-625-05)

55111-625-30 — 30 TABLET, FILM COATED in 1 BOTTLE (55111-625-30)

55111-625-60 — 60 TABLET, FILM COATED in 1 BOTTLE (55111-625-60)

55111-625-78 — 10 BLISTER PACK in 1 CARTON (55111-625-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-625-79)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-007 — Zafirlukast, 31722-008 — Zafirlukast, 42291-970 — zafirlukast, 42291-971 — zafirlukast, 55111-626 — Zafirlukast, 59651-291 — Zafirlukast, 59651-292 — Zafirlukast, 64380-187 — zafirlukast, 64380-188 — zafirlukast, 68084-059 — Zafirlukast, 72162-2361 — Zafirlukast

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.